 Bayer is an international pharmaceutical company based out of Germany. As of 2018, the company had a total of 116,998 employees globally. This is a significant increase from the previous years. In general, the number of employees at Bayer had remained stable until 2016 when Convestro, Bayer’s material science division, spun off into its own company. It increased again with the acquisition of Monsanto during 2018. Bayer’s company profile Bayer works in about four segments globally, pharmaceuticals, consumer health, crop science, and animal health. In August 2019, however, Bayer agreed to sell its animal health division to Elanco. Bayer’s yearly revenues have been variable in recent years but have still show significant growth since the 1990s. Most recently Bayer’s pharmaceutical and crop science segments have generated the most revenue for the company. However, among Bayer’s pharmaceutical segment the top pharmaceutical product was Xarelto, a blood thinning agent used in the treatment of blood clots. Bayer’s global positioning Bayer is among the top pharmaceutical companies in many regards. Bayer ranks as 14th among the top 50 global pharmaceutical companies based on the sales of their prescription drugs. Bayer was also ranked as the second most valuable pharmaceutical brand in recent years. Other major pharmaceutical companies such as Roche, Pfizer, and Abbott were listed among the most valuable pharmaceutical brands during that same year. 